Sentinel Lymph Node Biopsy and Neoadjuvant Chemotherapy in Breast Cancer Patients
Reference51 articles.
1. Mansel RE, Goyal A, Fallowfield L et al (2006) Sentinel node biopsy versus standard axillary treatment: results of the randomized multicentre UK ALMANAC trial. J Natl Cancer Inst 98:599–609
2. Purushotham AD, Upponi S, Klevesath MB, Bobrow L, Millar K, Myles JP et al (2005) Morbidity following sentinel lymph node biopsy in primary breast cancer – a randomized controlled trial. J Clin Oncol 23:4312–4321
3. Lyman GH, Guiliano AE, Somerfield MR et al (2005) The American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early stage breast cancer. J Clin Oncol 23:7703–7720
4. Benson JR, Querci della Rovere G, and the Axilla Management Consensus Group (2007) Management of the axilla in women with breast cancer. Lancet Oncol 8:331–348
5. Krag D, Anderson SJ, Julian TB et al (2010) Sentinel lymph node resection compared with conventional axillary lymph node dissection in clinically node negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11:927–933